Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

SENTINEL Investigators

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences